Observed effects in human trials Reported adverse events across the IV and oral trials included headache, fatigue, dizziness, nasopharyngitis, diarrhea, flatulence, increased appetite, nausea, and back pain
Energy levels often stabilize or improve by week 23 as your body adjusts to reduced calorie intake
Sweeteners: Sorbitol, Aspartame, Acesulfame K
Saxagliptin helps control blood sugar levels by inhibiting the enzyme DPP - 4, which leads to increased levels of the hormone glucagon - like peptide - 1 (GLP - 1) and glucose - dependent insulinotropic polypeptide (GIP)
The primary target of managing MASLD is lifestyle modification, including dietary changes and increased physical activity
I think there's a lot more to come in the next several years and when we have that information, we'll be able to give much more directed and precise advice